References
- Lipsky BA, Berendt AR, Embil J, De Lalla F.Diagnosing and treating diabetic foot infections.Diabetes Metab Res Rev2004;20:S56–64.
- Reichardt P, Handrick W, Linke A, Schille R, Kiess W.Leukocytopenia, thrombocytopenia and fever related to piperacillin/tazobactam treatment—a retrospective analysis in 38 children with cystic fibrosis.Infection1999;27:355–6.
- Pérez-Vázquez A, Pastor JM, Riancho JA.Immune thrombocytopenia caused by piperacillin/tazobactam.Clin Infect Dis1998;27:650–1.
- Gerber L, Wing EJ.Life-threatening neutropenia secondary to piperacillin/tazobactam therapy.Clin Infect Dis1995;21: 1047–8.
- Ruiz-irastorza G, Barreiro G, Aguirre C.Reversible bone marrow depression by high-dose piperacillin/tazobactam.Br J Haematol1996;95:611–2.
- Behbahani R, Kostman JR.Hypersensitivity reaction during prolonged use of piperacillin/tazobactam in treatment of osteomyelitis.Ann Pharmacother1995;29:936–7.
- Peralta FG, Sánchez MB, Roíz MP, Pena MA, Tejero MA, Arjona R.Incidence of neutropenia during treatment of bone-related infections with piperacillin–tazobactam.Clin Infect Dis2003;37:1568–72.
- Scheetz MH, McKoy JM, Parada JP, Djulbegovic B, Raisch DW, Yarnold PR, et al.Systematic review of piperacillin-induced neutropenia.Drug Saf2007;30: 295–306.
- Perry CM, Markham A.Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.Drugs1999;57:805–43.
- Neftel KA, Hauser SP, Müller MR.Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics.J Infect Dis1985;152:90–8.
- Patel RA, Gallagher JC.Drug fever.Pharmacotherapy2010;30:57–69.